Regeneron Pharmaceuticals
REGN
#324
Rank
NZ$125.75 B
Marketcap
NZ$1,200
Share price
-0.97%
Change (1 day)
23.69%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): NZ$8.78 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$14.91 Billion. In 2025 the company made an earning of NZ$8.80 Billion, an increase over its 2024 earnings that were of NZ$8.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$8.78 B-0.23%
2025 NZ$8.80 B9.43%
2024 NZ$8.04 B13.83%
2023 NZ$7.06 B-13.57%
2022 NZ$8.17 B-47.9%
2021 NZ$15.69 B144.75%
2020 NZ$6.41 B56.86%
2019 NZ$4.08 B-4.87%
2018 NZ$4.29 B22.86%
2017 NZ$3.49 B56.3%
2016 NZ$2.23 B8.55%
2015 NZ$2.06 B54.53%
2014 NZ$1.33 B11.14%
2013 NZ$1.20 B72.13%
2012 NZ$0.69 B-285.93%
2011 -NZ$0.38 Billion121.73%
2010 -NZ$0.17 Billion37.18%
2009 -NZ$0.13 Billion-14.6%
2008 -NZ$0.15 Billion-25.02%
2007 -NZ$0.2 Billion6.32%
2006 -NZ$0.19 Billion-186.52%
2005 NZ$0.20 B2103.7%
2004 NZ$9.5 M-105.66%
2003 -NZ$0.17 Billion-18.18%
2002 -NZ$0.21 Billion42.33%
2001 -NZ$0.15 Billion129.35%
2000 -NZ$62.87 Million51.87%
1999 -NZ$41.4 Million92.19%
1998 -NZ$21.54 Million66.23%
1997 -NZ$12.96 Million-55.49%
1996 -NZ$29.12 Million103.53%
1995 -NZ$14.31 Million-70.89%
1994 -NZ$49.14 Million-26.08%
1993 -NZ$66.47 Million114.67%
1992 -NZ$30.97 Million196.77%
1991 -NZ$10.44 Million87.88%
1990 -NZ$5.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.71 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.55 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$15.29 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.88 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$2.73 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.46 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA